Correction (DOI:10.1016/j.ajog.2006.02.013);Maternal herpes simplex virus antibody avidity and risk of neonatal herpes

American Journal of Obstetrics and Gynecology

Volumn 195, Issue 1, 2006, Pages 115-120

  Brown, Elizabeth L ^a   Morrow, Rhoda ^b,d   Krantz, Elizabeth M ^b   Arvin, Ann M ^e   Prober, Charles G ^e   Yasukawa, Linda L ^e   Corey, Lawrence ^b,c   Wald, Anna ^a,c  

^a Departments of Epidemiology   (United States)

^b Laboratory Medicine

^c UNIVERSITY OF WASHINGTON   (United States)

^d SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Avidity; Neonatal herpes

Indexed keywords

MATERNAL ANTIBODY; VIRUS ANTIBODY;

ANTIBODY AFFINITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INFANCY; INFANT; NEWBORN INFECTION; NEWBORN PERIOD; PREGNANCY; PRIMARY INFECTION; PRIORITY JOURNAL; RISK ASSESSMENT; SEROCONVERSION; SEROLOGY; SERUM; VERTICAL TRANSMISSION; VIRUS DETECTION; VIRUS INFECTION; VIRUS ISOLATION;

EID: 33745268905     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.08.033     Document Type: Erratum

References (22)

1. Brown Z.A., Wald A., Morrow R.A., Selke S., Zeh J., and Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 289 (2003) 203-209
2. Brown Z., Vontver L., Benedetti J., Critchlow C., Sells C., Berry S., et al. Effects on infants of first episode genital herpes during pregnancy. N Engl J Med 317 (1987) 1247-1251
3. Ashley R.L., and Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev 12 (1999) 1-8
4. Brown Z.A., Selke S.A., Zeh J., Kopelman J., Maslow A., Ashley R.L., et al. Acquisition of herpes simplex virus during pregnancy. N Engl J Med 337 (1997) 509-515
5. Brown Z.A. HSV-2 specific serology should be offered routinely to antenatal patients. Rev Med Virol 10 (2000) 141-144
6. Tranchat C., Van de Perre P., Simonon-Sorel A., Karita E., Benchaib M., Lepage P., et al. Maternal humoral factors associated with perinatal human immunodeficiency virus type-1 transmission in a cohort from Kigali, Rwanda, 1988-1994. J Infect 39 (1999) 213-220
7. Devash Y., Calvelli T.A., Wood D.G., Reagan K.J., and Rubinstein A. Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain. Proc Natl Acad Sci U S A 87 (1990) 3445-3449
8. Grangeot-Keros L., Mayaux M.J., Lebon P., Freymuth F., Eugene G., Stricker R., et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis 175 (1997) 944-946
9. Bodeus M., and Goubau P. Predictive value of maternal-IgG avidity for congenital human cytomegalovirus infection. J Clin Virol 12 (1999) 3-8
10. Lazzarotto T., Varani S., Guerra B., Nicolosi A., Lanari M., and Landini M.P. Prenatal indicators of congenital cytomegalovirus infection. J Pediatr 137 (2000) 90-95
11. Lazzarotto T., Spezzacatena P., Varani S., Gabrielli L., Pradelli P., Guerra B., et al. Anticytomegalovirus (anti-CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection. Clin Diagn Lab Immunol 6 (1999) 127-129
12. Hashido M., Inouye S., and Kawana T. Differentiation of primary from nonprimary genital herpes infections by a herpes simplex virus-specific immunoglobulin G avidity assay. J Clin Microbiol 35 (1997) 1766-1768
13. Morrow R.A., Friedrich D., Krantz E., and Wald A. Development and use of a type-specific antibody avidity test based on herpes simplex virus type 2 glycoprotein G. Sex Transm Dis 31 (2004) 508-515
14. Arvin A.M., Hensleigh P.A., Prober C.G., Au D.S., Yasukawa L.L., Wittek A.E., et al. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. N Engl J Med 315 (1986) 796-800
15. Prober C.G., Hensleigh P.A., Boucher F.D., Yasukawa L.L., Au D.S., and Arvin A.M. Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus. N Engl J Med 318 (1988) 887-891
16. Sullender W.M., Yasukawa L.L., Schwartz M., Pereira L., Hensleigh P.A., Prober C.G., et al. Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes. J Infect Dis 157 (1988) 164-171
17. Ashley R.L., Militoni J., Lee F., Nahmias A., and Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol 26 (1988) 662-667
18. Arellano M. Panel data econometrics (2003), Oxford University Press, New York (NY)
19. Ashley-Morrow R., Krantz E., and Wald A. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sex Transm Dis 30 (2003) 310-314
20. Lappalainen M., and Hedman K. Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity. Ann Ist Super Sanita 40 (2004) 81-88
21. Remington J.S., Thulliez P., and Montoya J.G. Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol 42 (2004) 941-945
22. Bodeus M., Van Ranst M., Bernard P., Hubinont C., and Goubau P. Anticytomegalovirus IgG avidity in pregnancy: a 2-year prospective study. Fetal Diagn Ther 17 (2002) 362-366